Edition:
United States

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

6.28USD
19 Oct 2018
Change (% chg)

$-0.22 (-3.38%)
Prev Close
$6.50
Open
$6.50
Day's High
$6.70
Day's Low
$6.23
Volume
92,879
Avg. Vol
119,427
52-wk High
$10.00
52-wk Low
$5.10

Chart for

About

Aduro Biotech, Inc. is an immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, including cancer. The Company's product candidates from its Live, Attenuated, Double-Deleted (LADD) Listeria monocytogenes, Stimulator of Interferon Genes... (more)

Overall

Beta: 2.24
Market Cap(Mil.): $482.26
Shares Outstanding(Mil.): 79.06
Dividend: --
Yield (%): --

Financials

  ADRO.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -1.21 -- --
ROI: -23.44 1.96 12.83
ROE: -42.91 1.12 14.95

BRIEF-Aduro Biotech Q1 Loss Per Share $0.28

* Q1 EARNINGS PER SHARE VIEW $-0.35 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

May 02 2018

Earnings vs. Estimates